ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
38.23
0.00%
US Tech 100
19,558.40
-0.10%
S&P 500
5,745.37
0.40%
US Dollar vs CAD
1.34756
-0.01%
Bitcoin
65,413.53
0.35%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Evolus Inc (EOLS)

  7. Evolus Inc (EOLS) News

EOLS

Evolus (EOLS)

Evolus Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:EOLS
DateTimeSourceHeadlineSymbolCompany
09/06/20248:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
09/06/20248:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
09/06/20247:00AMBusiness WireEvolus to Ring the Nasdaq Stock Market Closing Bell on Friday, September 13, 2024NASDAQ:EOLSEvolus Inc
09/04/20243:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
08/09/20243:30PMBusiness WireEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:EOLSEvolus Inc
07/31/20244:00PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EOLSEvolus Inc
07/31/20243:12PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EOLSEvolus Inc
07/31/20243:05PMBusiness WireEvolus Reports Second Quarter 2024 Results and Raises Full Year Revenue GuidanceNASDAQ:EOLSEvolus Inc
07/31/20247:00AMBusiness WireEvolus to Hold Investor Day on September 12, 2024NASDAQ:EOLSEvolus Inc
07/30/20247:00AMBusiness WireEvolus Expands Global Footprint with Introduction of Nuceiva® (botulinum toxin type A) in AustraliaNASDAQ:EOLSEvolus Inc
07/25/20247:00AMBusiness WireEvolus to Participate in the Canaccord Genuity 44th Annual Growth ConferenceNASDAQ:EOLSEvolus Inc
07/17/20247:00AMBusiness WireEvolus to Report Second Quarter Financial Results on July 31, 2024NASDAQ:EOLSEvolus Inc
07/01/20247:00AMBusiness WireEvolus Announces Appointment of Albert G. White III to Board of DirectorsNASDAQ:EOLSEvolus Inc
06/24/20247:00AMBusiness WireEvolus Announces Submission of Premarket Approval Application to the U.S. Food and Drug Administration for First Two Evolysse™ Dermal Filler ProductsNASDAQ:EOLSEvolus Inc
06/12/20247:00AMBusiness WireEvolus Broadens International Presence with Launch of Nuceiva® (botulinum toxin type A) in SpainNASDAQ:EOLSEvolus Inc
06/11/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EOLSEvolus Inc
06/07/20244:00PMBusiness WireEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:EOLSEvolus Inc
06/06/20246:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
06/06/20244:45PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EOLSEvolus Inc
06/05/20248:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
06/05/20244:22PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EOLSEvolus Inc
06/04/20243:25PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EOLSEvolus Inc
06/03/20244:53PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EOLSEvolus Inc
05/20/20247:30AMBusiness WireEvolus Announces Positive Data from Pivotal Trial for First Two Evolysse™ Dermal Filler Products at 2024 SCALE MeetingNASDAQ:EOLSEvolus Inc
05/15/20244:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
05/15/20247:30AMBusiness WireEvolus Celebrates Fifth Anniversary of Launching its Flagship Product Jeuveau® at the Women’s Wear Daily Beauty CEO SummitNASDAQ:EOLSEvolus Inc
05/14/20247:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
05/14/20247:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
05/14/20247:06PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EOLSEvolus Inc
05/10/20245:55PMBusiness WireEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:EOLSEvolus Inc
 Showing the most relevant articles for your search:NASDAQ:EOLS

Your Recent History

AMEX
IAF
abrdn Australia Equity
TG
8CZ
Zoomlion Heavy Industry ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved